Trials / Conditions / Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
4 registered clinical trials studyying Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers NCT05296005 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Active Not Recruiting | Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of NCT04929392 | City of Hope Medical Center | Phase 2 |
| Active Not Recruiting | Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal NCT03784326 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer NCT03776487 | M.D. Anderson Cancer Center | Phase 2 |